<?xml-stylesheet type='text/xsl' href='ctgovTransform.xsl'?>
<CT.GOV_Trial requestNumber="1070">
  <stage>Registered</stage>
  <submitdate>13/02/2006</submitdate>
  <approvaldate>13/02/2006</approvaldate>
  <nctid>NCT00292214</nctid>
  <trial_identification>
    <studytitle>Comparing Intravenous and Oral Paracetamol for Cholecystectomy</studytitle>
    <scientifictitle>Comparative Pharmacokinetics of Intravenous and Oral Paracetamol in the Peri-Operative Period of Laparoscopic Cholecystectomy</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>2005.138</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Laparoscopic Cholecystectomy</healthcondition>
  </conditions>
  <interventions>
    <interventions>Treatment: drugs - Paracetamol (acetaminophen)

Treatment: drugs: Paracetamol (acetaminophen)


</interventions>
    <comparator />
    <control />
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Early pharmacokinetics (0-240 minutes) of a single dose of 1g paracetamol in IV and oral formulations</outcome>
      <timepoint />
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Difference in analgesia achieved (15-120 minutes post-operative) with IV and oral paracetamol.</outcome>
      <timepoint />
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>-  Males and females aged 18-75

          -  Scheduled to have elective laparoscopic cholecystectomy under general anaesthesia</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>75</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>-  Inadequate English comprehension (difficult to obtain informed consent and
             cooperation), and when interpreters are not available.

          -  History of allergy or sensitivity to paracetamol

          -  Administration of oral paracetamol within previous 8 hours

          -  American Society of Anesthesiologists (ASA) grade IV or V, indicating serious
             cardio-respiratory co-morbidity

          -  Not suitable for protocol anaesthetic technique (eg: history of nausea and vomiting
             with morphine)</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 4</phase>
    <anticipatedstartdate />
    <actualstartdate>1/10/2005</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize />
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate />
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>VIC</recruitmentstate>
    <hospital>Royal Melbourne Hospital - Melbourne</hospital>
    <postcode>3052 - Melbourne</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Other</primarysponsortype>
    <primarysponsorname>Melbourne Health</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
  </sponsorship>
  <ethicsAndSummary>
    <summary>To determine the amount of paracetamol in the blood when given in either intravenous or oral
      forms prior to cholecystectomy. The clinical effectiveness of each form will also be
      evaluated with pain scores and the use of other pain relief drugs.</summary>
    <trialwebsite>https://clinicaltrials.gov/show/NCT00292214</trialwebsite>
    <publication />
    <ethicsreview />
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Malcolm Hogg, Anaesthetist</name>
      <address>Melbourne Health</address>
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Public Queries</type>
    </contact>
  </contacts>
</CT.GOV_Trial>